Vivani Medical (Vivani Medical) Debt-to-Equity : 0.71 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Vivani Medical Debt-to-Equity?

Vivani Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.43 Mil. Vivani Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $18.94 Mil. Vivani Medical's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $28.71 Mil. Vivani Medical's debt to equity for the quarter that ended in Mar. 2024 was 0.71.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Vivani Medical's Debt-to-Equity or its related term are showing as below:

VANI' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.45 Med: 0.68 Max: 1.27
Current: 0.71

During the past 4 years, the highest Debt-to-Equity Ratio of Vivani Medical was 1.27. The lowest was -1.45. And the median was 0.68.

VANI's Debt-to-Equity is ranked worse than
81.04% of 1081 companies
in the Biotechnology industry
Industry Median: 0.15 vs VANI: 0.71

Vivani Medical Debt-to-Equity Historical Data

The historical data trend for Vivani Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivani Medical Debt-to-Equity Chart

Vivani Medical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

1.27

0.74

0.02

1.00

Vivani Medical Quarterly Data
	Dec20	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial								0.03	0.65	0.80	1.00	0.71

Competitive Comparison of Vivani Medical's Debt-to-Equity

For the Biotechnology subindustry, Vivani Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vivani Medical's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivani Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Vivani Medical's Debt-to-Equity falls into.

Vivani Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Vivani Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.383	+	19.313)	/	20.761
	=	1.00

Vivani Medical's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.434	+	18.94)	/	28.71
	=	0.71

Vivani Medical (NAS:VANI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Vivani Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Vivani Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivani Medical (Vivani Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivani Medical Inc (NAS:VANI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

U5P:Germany

Address

5858 Horton Street, Suite 280, Emeryville, CA, USA, 94608

Website

https://www.vivani.com

Vivani Medical Inc is a preclinical stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases.

Executives

Gregg Williams	director, 10 percent owner	PO BOX 200, WALLED LAKE MI 48390-0200
Brigid Makes	officer: CFO	20245 SW 95TH AVENUE, TUALATIN OR 97062
Donald Dwyer	officer: Chief Business Officer	54 CHERRY FARM LANE, WEST CHESTER PA 19382
Aaron Mendelsohn	director	224 15TH STREET, SANTA MONICA CA 90402
Joachim Eberhard Bolck	10 percent owner	33 CLUB VIEW LANE, ROLLING HILLS ESTATES CA 90274
Lisa Ellen Porter	officer: Chief Medical Officer	778 CORDILLERAS AVE, SAN CARLOS CA 94070
Truc Le	officer: COO	1905 WEST RED FOX ROAD, SANTA ANA CA 92704
Adam Mendelsohn	director, officer: CEO	C/O 5858 HORTON ST. SUITE 280, EMERYVILLE CA 94608
Wilford Dean Baker	director	200 FLYNN ROAD, CAMARILLO CA 93012-8790
Larson Alexandra L.p.	director	3797 BURNING TREE DRIVE, BLOOMFIELD HILLS MI 48302
Scott Dunbar	officer: Acting CEO	13170 TELFAIR AVENUE, SYLMAR CA 91342
Edward Jonathon Sedo	officer: Controller	4485 FORESTGLEN CT, MOORPARK CA 93021
Jessy Dana Dorn	officer: VP-Clin & Scientific Affairs	12744 SAN FERNANDO RD. SUITE 400, SYLMAR CA 91342
Matthew J Pfeffer	director
Patrick Ryan	officer: Chief Operating Officer	C/O SECOND SIGHT MEDICAL PRODUCTS, INC., 12744 SAN FERNANDO ROAD, SUITE 400, SYLMAR CA 91342